PMID- 29458369 OWN - NLM STAT- MEDLINE DCOM- 20180412 LR - 20240313 IS - 1472-6882 (Electronic) IS - 1472-6882 (Linking) VI - 18 IP - 1 DP - 2018 Feb 20 TI - Is fasting safe? A chart review of adverse events during medically supervised, water-only fasting. PG - 67 LID - 10.1186/s12906-018-2136-6 [doi] LID - 67 AB - BACKGROUND: Evidence suggests that fasting, during which only water is consumed, results in potentially health promoting physiological effects. However, peer-reviewed research assessing the safety of water-only fasting is lacking. To address this, we conducted a chart review to describe adverse events (AEs) that occurred during medically supervised, water-only fasting. METHODS: Electronic charts from patient visits to a residential medical facility from 2006 to 2011 were reviewed. Patients who were at least 21 years of age and water-only fasted for >/=2 consecutive days with a refeeding period equal to half of the fast length were included. Out of 2539 charts, 768 visits met our inclusion and exclusion criteria. AEs were abstracted from chart notes and classified according to CTCAE (v4.03) and MedDRA (v12.1) terminology. Descriptive analysis of AEs is reported. RESULTS: During the protocol period, the highest grade AE (HGAE) in 555 visits was a grade 2 event or lower, in 212 visits it was a grade 3 event, in 1 visit it was a grade 4 event, and there were no grade 5 events. There were 2 (0.002%) visits with a serious adverse event (SAE). The majority of AEs identified were mild (n = 4490, 75%) in nature and known reactions to fasting. CONCLUSIONS: To our knowledge, this is the most comprehensive analysis of AEs experienced during medically supervised, water-only fasting conducted to date. Overall, our data indicate that the majority of AEs experienced were mild to moderate and known reactions to fasting. This suggests that the protocol used in this study can be safely implemented in a medical setting with minimal risk of a SAE. FAU - Finnell, John S AU - Finnell JS AD - AOMA Graduate School of Integrative Medicine, Austin, TX, 78745, USA. FAU - Saul, Bradley C AU - Saul BC AD - NoviSci, Durham, NC, USA. FAU - Goldhamer, Alan C AU - Goldhamer AC AD - TrueNorth Health Center, Santa Rosa, CA, 95404, USA. AD - TrueNorth Health Foundation, 1501 Pacific Avenue, Santa Rosa, CA, 95404, USA. FAU - Myers, Toshia R AU - Myers TR AD - TrueNorth Health Foundation, 1501 Pacific Avenue, Santa Rosa, CA, 95404, USA. toshia@truenorthhealth.com. LA - eng GR - NA/National Health Association/ PT - Clinical Trial PT - Journal Article DEP - 20180220 PL - England TA - BMC Complement Altern Med JT - BMC complementary and alternative medicine JID - 101088661 RN - 059QF0KO0R (Water) SB - IM MH - Adult MH - Aged MH - Fasting/*adverse effects/metabolism MH - Female MH - Humans MH - Male MH - Middle Aged MH - Water/*metabolism MH - Young Adult PMC - PMC5819235 OTO - NOTNLM OT - Adverse events OT - Fasting OT - Safety COIS- ETHICS APPROVAL AND CONSENT FOR PARTICIPATION: This study was approved by the Institutional Review Board (IRB) at the AOMA Graduate School of Integrative Medicine (AOMA: 2015-002). The research was conducted in accordance with the approved protocol and complied with the standards of the Declaration of Helsinki. This study involved a retrospective review of existing data that was de-identified prior to analysis and was granted a waiver of informed consent by the AOMA IRB. CONSENT FOR PUBLICATION: Not applicable for this study. COMPETING INTERESTS: ACG is the director of the TrueNorth Health Center, president of the board of the TrueNorth Health Foundation, and member of the board of the National Health Association. He does not receive financial compensation for these roles. BCS and TRM are paid consultants for the TrueNorth Health Foundation, which is funded in part by the TrueNorth Health Center. JSF received funds from the National Health Association grant. PUBLISHER'S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. EDAT- 2018/02/21 06:00 MHDA- 2018/04/13 06:00 PMCR- 2018/02/20 CRDT- 2018/02/21 06:00 PHST- 2017/05/17 00:00 [received] PHST- 2018/02/12 00:00 [accepted] PHST- 2018/02/21 06:00 [entrez] PHST- 2018/02/21 06:00 [pubmed] PHST- 2018/04/13 06:00 [medline] PHST- 2018/02/20 00:00 [pmc-release] AID - 10.1186/s12906-018-2136-6 [pii] AID - 2136 [pii] AID - 10.1186/s12906-018-2136-6 [doi] PST - epublish SO - BMC Complement Altern Med. 2018 Feb 20;18(1):67. doi: 10.1186/s12906-018-2136-6.